Compositions and methods for the treatment and prevention of disease

Details for Australian Patent Application No. 2006331356 (hide)

Owner Immupharma France SA

Inventors Renia, Laurent; Guichard, Gilles; Lallemand, Eliette; Lena, Gersande

Agent Shelston IP

Pub. Number AU-B-2006331356

PCT Pub. Number WO2007/074170

Priority 60/755,632 29.12.05 US; 11/644,626 22.12.06 US

Filing date 28 December 2006

Wipo publication date 5 July 2007

Acceptance publication date 1 December 2011

International Classifications

A61K 31/395 (2006.01) - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/06 (2006.01) Antiparasitic agents

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/074170 Priority application(s): WO2007/074170

11 September 2008 Amendment Made

  The nature of the amendment is: Amend the priority details to include 11/644,626 22 Dec 2006 US 2006331357 Immupharma France SA The nature of the amendment is: Amend the name of the inventor to read Renia, Laurent; Lena, Gersande; Guichard, Gilles and Lallemand, Eliette

1 December 2011 Application Accepted

  Published as AU-B-2006331356

29 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006331357-Compositions and methods for synthesizing novel heterocyclic therapeutics

2006331355-Compositions and methods for the inhibition of phospholipase A2